{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:40:48Z","timestamp":1780569648474,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jocd.2024.101538","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:37:50Z","timestamp":1729622270000},"page":"101538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the Effect of Selective Serotonin and Norepinephrine Reuptake Inhibitors on Bone Mineral Density with Selective Serotonin Reuptake Inhibitors and Healthy Controls"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-5982","authenticated-orcid":false,"given":"S\u00fcheyla","family":"Do\u011fan Bulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-6619","authenticated-orcid":false,"given":"Gamze","family":"Zengin \u0130spir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-4873","authenticated-orcid":false,"given":"Serdar","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0269-3598","authenticated-orcid":false,"given":"Emine","family":"AK Ayg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9773","key":"10.1016\/j.jocd.2024.101538_bib0001","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.jocd.2024.101538_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.jocd.2024.101538_bib0003","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3390\/jcm11092382","article-title":"Secondary osteoporosis and metabolic bone diseases","volume":"11","author":"Sobh","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jocd.2024.101538_bib0004","article-title":"Pharmacological neuroenhancement: current aspects of categorization, epidemiology, pharmacology, drug development, ethics, and future perspectives","volume":"2021","author":"Daubner","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.jocd.2024.101538_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/11633300-000000000-00000","article-title":"Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss: a population-based cohort study","volume":"26","author":"Zucker","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocd.2024.101538_bib0006","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00198-014-2649-x","article-title":"Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)","volume":"25","author":"Moura","year":"2014","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.jocd.2024.101538_bib0007","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/gps.4974","article-title":"Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: a systematic review and meta-analysis","volume":"33","author":"Khanassov","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.jocd.2024.101538_bib0008","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1038\/s41598-021-92821-9","article-title":"Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study","volume":"11","author":"Kang","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jocd.2024.101538_bib0009","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"31","key":"10.1016\/j.jocd.2024.101538_bib0010","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocd.2024.101538_bib0011","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00198-012-2170-z","article-title":"Serotonin\u2013norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption","volume":"24","author":"Shea","year":"2013","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jocd.2024.101538_bib0012","first-page":"121","article-title":"Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies","volume":"8","author":"Warden","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"5","key":"10.1016\/j.jocd.2024.101538_bib0013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jocd.2024.101538_bib0014","first-page":"123","article-title":"Bone and brain: a review of neural, hormonal, and musculoskeletal connections","volume":"24","author":"Jones","year":"2004","journal-title":"Iowa Orthop J"},{"issue":"5","key":"10.1016\/j.jocd.2024.101538_bib0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/bph.12000","article-title":"Noradrenaline stimulates cell proliferation by suppressing potassium channels via Gi\/o-protein-coupled \u03b11B-adrenoceptors in human osteoblasts","volume":"168","author":"Kodama","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"42","key":"10.1016\/j.jocd.2024.101538_bib0016","doi-asserted-by":"crossref","first-page":"30105","DOI":"10.1074\/jbc.M113.481309","article-title":"Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis","volume":"288","author":"Ma","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jocd.2024.101538_bib0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S8756-3282(98)00099-4","article-title":"Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells","volume":"23","author":"Suzuki","year":"1998","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jocd.2024.101538_bib0018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.jocd.2024.101538_bib0019","first-page":"16876","article-title":"Depression induces bone loss through stimulation of the sympathetic nervous system","volume":"103","author":"Yirmiya","year":"2006","journal-title":"PNAS Nexus"},{"issue":"10","key":"10.1016\/j.jocd.2024.101538_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107761","article-title":"The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice","volume":"26","author":"Donat","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jocd.2024.101538_bib0021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-014-2859-2","article-title":"Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study","volume":"26","author":"Ak","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2024.101538_bib0022","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials","volume":"180","author":"Hayasaka","year":"2015","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.jocd.2024.101538_bib0023","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1248\/bpb.b16-00298","article-title":"Influence of genetic polymorphisms and concomitant anxiolytic doses on antidepressant maintenance doses in Japanese patients with depression","volume":"39","author":"Inoue","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jocd.2024.101538_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jocd.2024.101538_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/comp.2001.19756","article-title":"Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale","volume":"42","author":"Akdemir","year":"2001","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jocd.2024.101538_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"issue":"2","key":"10.1016\/j.jocd.2024.101538_bib0027","first-page":"114","article-title":"Hamilton Anxiety Rating Scale: Interrater Reliabilty and Validity Study","volume":"9","author":"Yaz\u0131c\u0131","year":"1998","journal-title":"Turk Psikiyatri Derg"},{"key":"10.1016\/j.jocd.2024.101538_bib0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.jocd.2024.101538_bib0029","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S8756-3282(00)00381-1","article-title":"Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis","volume":"27","author":"Kanis","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2024.101538_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-018-0476-3","article-title":"OFELIA: prevalence of osteoporosis in fragility fracture patients","volume":"104","author":"Tei","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.jocd.2024.101538_bib0031","doi-asserted-by":"crossref","first-page":"648","DOI":"10.21608\/ejhm.2019.23682","article-title":"Effect of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors on trabecular bone score and bone mineral density in primary fibromyalgia","volume":"74","author":"Hamoud","year":"2019","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jocd.2024.101538_bib0032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002239900270","article-title":"Effect of tobacco consumption on bone mineral density in healthy young males","volume":"60","author":"Ortego-Centeno","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2024.101538_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.maturitas.2016.07.010","article-title":"Smoking, alcohol and caffeine in relation to two hormonal indicators of ovarian age during the reproductive years","volume":"92","author":"Kline","year":"2016","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.jocd.2024.101538_bib0034","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1359\/jbmr.1999.14.2.215","article-title":"Smoking increases bone loss and decreases intestinal calcium absorption","volume":"14","author":"Krall","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jocd.2024.101538_bib0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ejcn.1600870","article-title":"The influence of smoking on vitamin D status and calcium metabolism","volume":"53","author":"Brot","year":"1999","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jocd.2024.101538_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/endrev\/bnad025","article-title":"Crosstalk between the neuroendocrine system and bone homeostasis","volume":"45","author":"Zhao","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jocd.2024.101538_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115810","article-title":"Antidepressant duloxetine hydrochloride protects against ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation","volume":"168","author":"Zhou","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jocd.2024.101538_bib0038","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","article-title":"Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose","volume":"24","author":"Vestergaard","year":"2013","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2024.101538_bib0039","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-009-0849-6","article-title":"Use of anti-depressants and the risk of fracture of the hip or femur","volume":"20","author":"van den Brand","year":"2009","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jocd.2024.101538_bib0040","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jgs.16404","article-title":"Multinational investigation of fracture risk with antidepressant use by class, drug, and indication","volume":"68","author":"Tamblyn","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocd.2024.101538_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106481","article-title":"Duloxetine strengthens osteoblast activation by prostaglandin E1: upregulation of p38 MAP kinase","volume":"151","author":"Tachi","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"10.1016\/j.jocd.2024.101538_bib0042","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/bcb-2020-0347","article-title":"Duloxetine suppresses BMP-4-induced release of osteoprotegerin via inhibition of the SMAD signaling pathway in osteoblasts","volume":"99","author":"Tachi","year":"2021","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jocd.2024.101538_bib0043","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1152\/ajpregu.2001.280.1.R79","article-title":"Repeated immobilization stress reduces rat vertebral bone growth and osteocalcin","volume":"280","author":"Patterson-Buckendahl","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jocd.2024.101538_bib0044","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2015.04.029","article-title":"Negative effect of serotonin\u2013norepinephrine reuptake inhibitor therapy on rat bone tissue after orchidectomy","volume":"761","author":"Fekete","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.jocd.2024.101538_bib0045","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1532-5415.2002.50453.x","article-title":"Central nervous system\u2013active medications and risk for falls in older women","volume":"50","author":"Ensrud","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.jocd.2024.101538_bib0046","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpedi.162.12.1181","article-title":"Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls","volume":"162","author":"Dorn","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jocd.2024.101538_bib0047","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-015-3213-z","article-title":"Serotonergic antidepressant use and the risk of fracture: a population-based nested case\u2013control study","volume":"27","author":"Wang","year":"2016","journal-title":"Osteoporos Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695024000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695024000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:49:29Z","timestamp":1738115369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695024000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1094695024000714"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2024.101538","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Effect of Selective Serotonin and Norepinephrine Reuptake Inhibitors on Bone Mineral Density with Selective Serotonin Reuptake Inhibitors and Healthy Controls","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2024.101538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101538"}}